AI Article Synopsis
- Two cases of seroma formation were reported after surgeries using recombinant human bone morphogenetic protein-2 (rhBMP-2) in posterior cervical fusion.
- Although rhBMP-2 is considered safe by some for off-label use in these procedures, there is limited information on its complication rates.
- The findings suggest that rhBMP-2 increases the risk of seromas, indicating the need for postoperative drains and potentially requiring MRI for symptom evaluation.
Article Abstract
Case: We present 2 cases of postoperative seroma formation following posterior cervical fusion with the use of recombinant human bone morphogenetic protein-2 (rhBMP-2).
Conclusion: Although some who advocate for the off-label use of rhBMP-2 in patients undergoing posterior cervical spine fusion believe it to be safe, relatively little has been published regarding complication rates. We believe that rhBMP-2 carries a risk of seroma formation in patients who undergo posterior cervical fusion, which necessitates the use of a postoperative drain. Surgeons should have a low threshold for obtaining postoperative magnetic resonance imaging in a symptomatic patient.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.CC.18.00089 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!